238 related articles for article (PubMed ID: 7913445)
1. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: an anatomical and behavioral analysis.
Costantini LC; Vozza BM; Snyder-Keller AM
Exp Neurol; 1994 Jun; 127(2):219-31. PubMed ID: 7913445
[TBL] [Abstract][Full Text] [Related]
2. Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants.
Costantini LC; Snyder-Keller A
Exp Neurol; 1997 May; 145(1):214-27. PubMed ID: 9184123
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study.
Mendez I; Elisevich K; Flumerfelt B
J Comp Neurol; 1991 Jun; 308(1):66-78. PubMed ID: 1714923
[TBL] [Abstract][Full Text] [Related]
4. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena.
Snyder-Keller AM
Exp Neurol; 1991 Aug; 113(2):155-65. PubMed ID: 1831151
[TBL] [Abstract][Full Text] [Related]
5. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
7. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
8. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
Nishino H; Hida H; Takei N; Kumazaki M; Nakajima K; Baba H
Exp Neurol; 2000 Jul; 164(1):209-14. PubMed ID: 10877931
[TBL] [Abstract][Full Text] [Related]
9. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons.
Di Loreto S; Florio T; Capozzo A; Napolitano A; Adorno D; Scarnati E
Exp Neurol; 1996 Apr; 138(2):318-26. PubMed ID: 8620930
[TBL] [Abstract][Full Text] [Related]
11. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants.
Winkler C; Bentlage C; Nikkhah G; Samii M; Björklund A
Exp Neurol; 1999 Feb; 155(2):165-86. PubMed ID: 10072293
[TBL] [Abstract][Full Text] [Related]
12. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
Törnqvist N; Björklund L; Strömberg I
Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
McPherson RJ; Marshall JF
Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
[TBL] [Abstract][Full Text] [Related]
14. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons.
Sortwell CE; Collier TJ; Sladek JR
J Comp Neurol; 1998 Oct; 399(4):530-40. PubMed ID: 9741481
[TBL] [Abstract][Full Text] [Related]
15. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and anatomical correlates of immunologically induced rejection of nigral xenografts.
Carder RK; Snyder-Keller AM; Lund RD
J Comp Neurol; 1988 Nov; 277(3):391-402. PubMed ID: 2904453
[TBL] [Abstract][Full Text] [Related]
17. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway.
Annett LE; Martel FL; Rogers DC; Ridley RM; Baker HF; Dunnett SB
Exp Neurol; 1994 Feb; 125(2):228-46. PubMed ID: 7906227
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
19. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
Ostergaard K; Jones SA; Hyman C; Zimmer J
Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
[TBL] [Abstract][Full Text] [Related]
20. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
Yurek DM
Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
